Pharmacists play a crucial role in managing headaches in patients on complement inhibitors for PNH, ensuring proper education and risk mitigation strategies.
Mona El-Mouwfi, PharmD Candidate
Advertisement
Articles by Mona El-Mouwfi, PharmD Candidate
Mona El-Mouwfi explores how pharmacists enhance hydroxyurea therapy for sickle cell disease, improving patient outcomes and addressing treatment barriers effectively.
Advertisement
Latest Updated Articles
Changing the Course of SCD: One Dose of Hydroxyurea at a TimePublished: August 4th 2025 | Updated:
Headache or Harm: A Pharmacist’s Role in Differentiating Complement Inhibitor Adverse EffectsPublished: August 7th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nerandomilast Receives FDA Approval for Idiopathic Pulmonary Fibrosis
2
Study Shows Infliximab Biosimilar is Safe in Patients Undergoing RA Treatment
3
Dexamethasone-Sparing Regimen Offers Safer Option for Frail Patients With MM
4
Pneumococcal Polysaccharide Vaccination Does Not Reduce Rates of Cardiovascular Events
5
